13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Autor: | Elstein, Deborah, Abrahamov, Aya, Oz, Anat, Arbel, Naama, Baris, Hagit, Zimran, Ari |
---|---|
Zdroj: | In Blood Cells, Molecules and Diseases December 2015 55(4):415-418 |
Databáze: | ScienceDirect |
Externí odkaz: |